Clinical Trials

50 trials registered for Angelman Syndrome

Natural History Study for Patients With Angelman Syndrome
NCT06229769N/ACentre Hospitalier Universitaire de Liege
Recruiting
REVEAL: A Phase 3 Study of ION582 in Angelman Syndrome
NCT06914609Phase 3Ionis Pharmaceuticals, Inc.
Recruiting
Structural-functional Connectome in Drug-resistant Epilepsies and Neurodevelopmental Syndromes With Epilepsy
NCT06353620N/AIRCCS Eugenio Medea
Recruiting
Study of the Prevalence of Autistic Traits in Angelman Syndrome
NCT06337383N/AIRCCS Eugenio Medea
Recruiting
The Global Angelman Syndrome Registry
NCT05293184N/AFoundation for Angelman Syndrome Therapeutics, Australia
Recruiting
Use of Eye Tracking to Study Social Perception Abnormalities in Children With Angelman Syndrome
NCT06737718N/AAssistance Publique - Hôpitaux de Paris
Recruiting
Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)
NCT06139172N/ARush University Medical Center
Recruiting
An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome
NCT03882918Phase 3Healx AI
Terminated
Angelman Syndrome Natural History Study-FAST UK
NCT05100810N/AUniversity of Oxford
Unknown
An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder
NCT02226458Phase 2Edison Pharmaceuticals Inc
Withdrawn